Is a complete BCBA/MRK research report available?

No complete published report is available for bcba/MRK (BCBA/MRK) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

bcba/MRK stock profile: metrics, valuation and analysis

Market cap	536.7T
Revenue (ttm)	98.6T
Net income (ttm)	4.7T
EPS (ttm)	ARS 1,886
P/E (trailing)	114.2x
P/E (forward)	16.4x
Dividend	ARS 723 (1.57%)
Volume	3,602
Beta	0.23

All BCBA/MRK indicators

Market & fundamental data

Available fields

238

Groups with data

Currency

USD

Showing 238 of 238 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	AR
Employees	74,000
Employees Change	0%
Employees Change Percent	0
Enterprise value	ARS 607.5T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	US58933Y1055
Last refreshed	2026-09-12
Market cap	ARS 536.7T
Price	ARS 46,060
Price currency	ARS
Rev Per Employee	1,332,729,371.62x
Sector	Healthcare
Sic	2834
Symbol	bcba/MRK
Website	https://www.merck.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.88%
EV Earnings	129.23x
EV/EBIT	17.12x
EV/EBITDA	13.72x
EV/FCF	25.53x
EV/Sales	6.04x
FCF yield	4.43%
Forward P/E	16.37x
P/B ratio	8.63x
P/E ratio	114.18x
P/S ratio	5.44x
PE Ratio10 Y	56.04x
PE Ratio3 Y	100.29x
PE Ratio5 Y	71.09x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	35.28%
EBITDA Margin	43.37%
FCF margin	23.68%
Gross margin	75.9%
Gross Profit	ARS 74.9T
Gross Profit Growth	2.6%
Gross Profit Growth Q	0.52%
Gross Profit Growth3 Y	5.77%
Gross Profit Growth5 Y	9.69%
Net Income	ARS 4.7T
Net Income Growth	-80.66%
Net Income Growth3 Y	0.66%
Net Income Growth5 Y	-10.64%
Pretax Margin	8.94%
Profit Margin	4.77%
Profit Per Employee	ARS 63.5M
ROA	11.87
Roa5y	11.18
ROCE	23.01
ROE	6.96
Roe5y	30.37
ROIC	14.05
Roic5y	22.36

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	90.71%
Cagr15y	75.38%
Cagr1y	95.52%
Cagr20y	54.54%
Cagr3y	44.45%
Cagr5y	79.12%
Div CAGR10	85.22%
Div CAGR3	99.73%
Div CAGR5	18.42%
EPS Growth	-80.37
EPS Growth3 Y	1.25
EPS Growth5 Y	-10.38
FCF Growth	9.11%
FCF Growth Q	77.03%
FCF Growth Qo Q	52.96%
FCF Growth3 Y	14.05%
FCF Growth5 Y	18.23%
OCF Growth	7.73%
OCF Growth Q	63.07%
OCF Growth Qo Q	37.06%
OCF Growth10 Y	5.83%
OCF Growth3 Y	9.82%
OCF Growth5 Y	10.91%
Revenue Growth	4.64x
Revenue Growth Q	5.07x
Revenue Growth Qo Q	1.97x
Revenue Growth3 Y	4.51x
Revenue Growth5 Y	8.68x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ARS 0.54
Assets	ARS 192.3T
Cash	ARS 10.6T
Current Assets	ARS 55.4T
Current Liabilities	ARS 41.9T
Debt	ARS 79.9T
Debt EBITDA	ARS 1.84
Debt Equity	ARS 1.28
Debt FCF	ARS 3.36
Equity	ARS 62.2T
Interest Coverage	13.47
Liabilities	ARS 130.1T
Long Term Assets	ARS 136.9T
Long Term Liabilities	ARS 88.2T
Net Cash	ARS -69.3T
Net Cash By Market Cap	ARS -12.91
Net Debt EBITDA	ARS 1.62
Net Debt Equity	ARS 1.11
Net Debt FCF	ARS 2.91
Tangible Book Value	ARS -6.9T
Tangible Book Value Per Share	ARS -2,777
WACC	5

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.32
Inventory Turnover	2.51
Net Working Capital	ARS 6.9T
Quick ratio	0.74
Working Capital	ARS 13.3T
Working Capital Turnover	ARS 9,874

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.92%
Dividend Growth	46.61%
Dividend Growth Years	3%
Dividend per share	ARS 723
Dividend Years	29
Dividend Yield	1.57%
Ex Div Date	2026-09-15
Last Dividend	ARS 257
Payout Frequency	Quarterly
Payout Ratio	261.52%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	63,495.38%
1Y total return	95.43%
200-day SMA	36,220.8
3Y total return	201.49%
50-day SMA	43,210.3
50-day SMA vs 200-day SMA	50over200
5Y total return	1,742.83%
All Time High	50,125
All Time High Change	-8.11%
All Time High Date	2026-08-25
All Time Low	5.74
All Time Low Change	802,339.02%
All Time Low Date	2000-03-06
ATR	1,400
Beta	0.23
Ch YTD	42.69
High	46,540
High52	50,125
High52 Date	2026-08-25
High52ch	-8.11%
Low	44,800
Low52	21,600
Low52 Date	2025-09-25
Low52ch	113.24%
Ma50ch	6.59%
Price vs 200-day SMA	27.16%
RSI	51.02
RSI Monthly	75.45
RSI Weekly	67.11
Sharpe ratio	1.95x
Sharpe Ratio3y	1.19x
Sharpe Ratio5y	1.59x
Sortino ratio	3.61
Sortino Ratio3y	2.02
Sortino Ratio5y	2.64
Total Return	3.49%
Tr YTD	44.3
Tr15y	456,790.78%
Tr1m	11.53%
Tr1w	-3.48%
Tr3m	29.1%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,463,032,888%
Net Borrowing	28,206,555,357,440
Shares Insiders	0.05%
Shares Institutions	81.51%
Shares Qo Q	-0.08%
Shares Yo Y	-1.92%
Short Ratio	2.9

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ARS 22.5T
Adjusted OCF	28,259,612,500,000
Average Volume	2,686.05x
Bv Per Share	25,165.1
CAPEX	ARS -5.8T
Ch10y	48,054.7
Ch15y	317,555.2
Ch1m	11.53
Ch1w	-3.48
Ch1y	91.04
Ch20y	371,351.6
Ch3m	28.23
Ch3y	185.8
Ch5y	1,608.5
Ch6m	34.21
Change	-0.52%
Change From Open	-0.22
Close	46,300
Days Gap	-0.3
Depreciation Amortization	8,132,326,640,940
Dollar Volume	165,908,120
Earnings Date	2026-10-29
EBIT	ARS 34.8T
EBITDA	ARS 42.8T
EPS	ARS 1,886
F Score	4
FCF	ARS 23.8T
FCF EV Yield	3.92x
Financing CF	9,140,855,000,000
Fiscal Year End	December
Founded	1,891
Goodwill	32,574,586,778,910
Graham Number	6960.41205
Graham Upside	-84.89
Income Tax	ARS 4.1T
Investing CF	-40,439,024,000,000
Is Primary Listing	0
Last Earnings Date	2026-08-04
Last Report Date	2026-06-30
Lynch Fair Value	ARS 2,017
Lynch Upside	-95.62
Ma150	37,728.5
Ma150ch	22.08%
Ma20	47,376.8
Ma20ch	-2.78%
Net CF	-1,751,133,000,000
Next Earnings Date	2026-10-29
Open	46,160
P FCF Ratio	22.55
P FCF Ratio SBC	23.88
P OCF Ratio	18.14
P OCF Ratio SBC	18.99
Payment Date	2026-10-07
Position In Range	72.41
Ppne	38,845,896,577,185
Price Date	2026-09-11
Price EBITDA	ARS 12.55
Relative Volume	1.3x
Revenue	98,621,973,500,000x
SBC By Revenue	1.34x
Share Based Comp	1,321,498,000,000
Tax By Revenue	4.17x
Tax Rate	46.72%
Tr20y	603,243.78%
Tr6m	35.72%
Volume	3,602
Z Score	3.6

BCBA/MRK (BCBA/MRK)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/MRK

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/MRK indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on BCBA/MRK

Frequently asked questions